Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VCL-NB01
- Development stage
- Discontinued
- Lead developer
- Vical
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
VCL-NB01 is an experimental DNA plasmid-based veterinary vaccine developed by Vical for the prevention of necrotic bovine pododermatitis, commonly known as foot rot, in cattle. The vaccine consists of a DNA plasmid encoding the leukotoxin (LKT) of *Fusobacterium necrophorum*, which is the primary causative agent of the disease. Upon intramuscular injection, the plasmid is taken up by the animal's cells, leading to the expression of the LKT protein and the subsequent induction of a protective immune response. This DNA-based approach was intended to offer improved efficacy and safety compared to traditional killed-bacteria vaccines (bacterins) by specifically targeting a key virulence factor of the pathogen.
- Other names
- Bovine foot rot DNA vaccine
02
Targets
Lkt (Fusobacterium necrophorum leukotoxin)
Beyond the preview
Go deeper on VCL-NB01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VCL-NB01.